Andrologia · 2017 · 13 citations · 20 references
MedicinePharmacologyPhysiologyDiabetologyReproductive EndocrinologyReproductive PhysiologyAntioxidant DefenseDiabetes MellitusOxidative StressOxidative Stress MechanismsRodent EndocrinologyTesticular PhysiologyAntioxidant TreatmentControl Group DesignDiabetes-related Erectile DysfunctionEjaculatory Function AssessmentMale FunctionMale Sexual FunctionOxidative Stress In DiabetesOxidative Stress Injury
Diabetes mellitus (DM) affects the male ejaculatory function. This study was designed to evaluate the role of oxidative stress in the development of diabetes-induced dysfunction of vas deferens (VD) in the rat. DM was induced by streptozotocin in 40 male Wistar rats. Subsequently, the diabetic animals were divided into three groups: DM group, DM + Eda group and DM + Tau group. These groups were administered saline, edaravone and taurine, respectively, daily for 4 weeks. Another group of ten rats served as a control group. DM was diagnosed in the 40 streptozotocin-injected rats. DM significantly reduced the VD weight. Additionally, DM induced in vitro VD hypercontractility, VD histological abnormalities and increased the serum and VD tissue concentration of malondialdehyde. VD immunohistochemistry revealed overexpression of three markers of oxidative stress. DM significantly reduced serum testosterone levels. No live birth was documented in all DM rats in mating experiments. Antioxidants significantly improved all the aforementioned parameters, except the testosterone levels. This study indicates a deleterious impact of DM-induced oxidative stress on VD histological and functional features. Antioxidant treatment may provide an adjunct tool to alleviate ejaculatory disorders for male patients with type 1 diabetes.
20
Michael Spedding · Trends in Pharmacological Sciences · 1985 · 157 citations
Oxidative stress tests: overview on reliability and use. Part I.
Beniamino Palmieri, Sblendorio · PubMed · 2008 · 144 citations
Neuroprotective effects of edaravone-administration on 6-OHDA-treated dopaminergic neurons
Wen Yuan, Takao Yasuhara, Tetsuro Shingo et al. · BMC Neuroscience · 2008 · 85 citations · Full text
Medicine, Neuroscience, Pharmacology +17